Literature DB >> 19239918

Chronotherapeutic drug delivery for early morning surge in blood pressure: a programmable delivery system.

Usha Yogendra Nayak1, Gopal Venktesh Shavi, Yogendra Nayak, Ranjith Kumar Averinen, Srinivas Mutalik, Sreenivasa Meka Reddy, Purshottam Das Gupta, Nayanabhirama Udupa.   

Abstract

The purpose of the study was to develop pulsatile capsule dosage form of valsartan for controlled delivery. In the majority of individuals blood pressure rises in the early morning hours, which lead to serious cardiovascular complications. Formulations with constant/programmable delivery rates make it possible to deliver drug at definite time or controlled rate in chronopharmacokinetic studies. The prepared system contained swellable polymer (l-hydroxypropyl cellulose (L-HPC), xanthan gum, polyethylene oxide or sodium alginate) together with drug tablet and erodible tablet (L-HPC or guar gum) in a pre-coated capsule. Various formulation factors were investigated through series of tests, in vitro dissolution and ex vivo continuous dissolution-absorption studies. We found that the type, amount of polymers and erodible tablet influenced the drug release. The formulation containing 200 mg sodium alginate and erodible tablet (150 mg) containing 50% guar gum and 46% lactose showed 5-6 h lag time and 10+/-2.1% drug release in initial 6 h following rapid release (99+/-1.7% release in 12 h) of drug was observed. The continuous dissolution-absorption study conducted using everted rat intestinal segment indicated delay in absorption of drug. Thus this approach can provide a useful means for timed release of valsartan and may be helpful for patients with morning surge.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19239918     DOI: 10.1016/j.jconrel.2009.02.008

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  8 in total

Review 1.  Circadian rhythms have broad implications for understanding brain and behavior.

Authors:  Rae Silver; Lance J Kriegsfeld
Journal:  Eur J Neurosci       Date:  2014-05-05       Impact factor: 3.386

Review 2.  Nocturnal blood pressure, morning blood pressure surge, and cerebrovascular events.

Authors:  Yuichiro Yano; Kazuomi Kario
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

3.  Chronotherapeutic Drug Delivery of Ketoprofen and Ibuprofen for Improved Treatment of Early Morning Stiffness in Arthritis Using Hot-Melt Extrusion Technology.

Authors:  Nagi Reddy Dumpa; Sandeep Sarabu; Suresh Bandari; Feng Zhang; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2018-07-02       Impact factor: 3.246

4.  Gastroretentive pulsatile release tablets of lercanidipine HCl: development, statistical optimization, and in vitro and in vivo evaluation.

Authors:  Gagganapalli Santhoshi Reddy; Usha Yogendra Nayak; Praful Balavant Deshpande; Srinivas Mutalik
Journal:  ScientificWorldJournal       Date:  2014-11-26

5.  Fractal properties and morphological investigation of Nano hydrochlorothiazide is used to treat hypertension.

Authors:  Amir Kazemi Korayem; Shahriar Ghamami; Zahra Bahrami
Journal:  BMC Pharmacol Toxicol       Date:  2018-11-09       Impact factor: 2.483

Review 6.  Application of coating technology to chronotherapeutic drug delivery systems: Recent publications and patents.

Authors:  Buduru Gowthami; S V Gopala Krishna; D Subba Rao
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-01-30

7.  Design of Chronomodulated Drug Delivery System of Valsartan: In Vitro Characterization.

Authors:  M Sokar; A Hanafy; A Elkamel; S El-Gamal
Journal:  Indian J Pharm Sci       Date:  2015 Jul-Aug       Impact factor: 0.975

8.  Development of Nanocrystal Compressed Minitablets for Chronotherapeutic Drug Delivery.

Authors:  Nagaraja Sreeharsha; Nimbagal Raghavendra Naveen; Posina Anitha; Prakash S Goudanavar; Sundarapandian Ramkanth; Santosh Fattepur; Mallikarjun Telsang; Mohammed Habeebuddin; Md Khalid Answer
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.